Yield of left ventricular dyssynchrony by gated SPECT MPI in patients with heart failure prior to implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator: Characteristics and prediction of cardiac outcome
- 210 Downloads
Mechanical left ventricular dyssynchrony (MLVD) might contribute in the therapeutic decision-making in patients with heart failure (HF) prior to cardiac resynchronization therapy (CRT). Our aim was to assess MLVD in patients with HF prior to implantable cardioverter-defibrillator (ICD) compared to patients with CRT-D.
In a prospective study, patients with LVEF ≤ 35% who were scheduled for ICD or CRT-D, underwent gated SPECT myocardial perfusion imaging with technetium 99m sestamibi within 3 months prior procedure. MLVD was measured by phase analysis.
The study cohort consisted of 143 patients, 71 with ICD and 72 with CRT-D. Age 68.3 ± 11 and LVEF 24 ± 6%. Phase standard deviation (SD) was 62.5 ± 18 and 59.7 ± 20 (P = NS), respectively. During follow-up of 23.7 ± 12.1 months, there were 10 vs 14 cardiac death in ICD and CRT-D, respectively (P = NS), hospitalization for HF, in 34 vs 53 (P < .001). In multivariate analysis, Phase SD was the independent predictor for cardiac death [HR 2.66 (95% CI 1.046-6.768), P = .04]. Kaplan-Meier curves of phase SD of 60° significantly identified ICD patients with and without cardiac deaths and hospitalization for HF exacerbation.
MLVD by phase SD can identify patients with cardiac events and predict cardiac death in patients treated with ICD.
KeywordsMechanical left ventricular dyssynchrony gated SPECT MPI phase SD CRT-D ICD cardiac outcome
Cardiac resynchronization therapy with a defibrillator
Implantable cardiac defibrillator
Left ventricular ejection fraction
Mechanical left ventricular dyssynchrony
Myocardial perfusion imaging
New York Heart Association
Single-photon emission computed tomography
Ventricular tachycardia/ventricular fibrillation
Conflict of interest
The authors report no potential conflict of interest relevant to this article.
- 7.Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.CrossRefPubMedGoogle Scholar
- 11.Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: Development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 2005;12:687-95.CrossRefPubMedGoogle Scholar
- 13.Boogers MM, Van Kriekinge SD, Hennemam MM, Ypenburg C, Van Bommel RJ, Boersma E, et al. Quantitative gates SPECT derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy. J Nucl Med 2009;50:718-25.CrossRefPubMedGoogle Scholar
- 14.Samad Z, Atchley AE, Trimble MA, Sun JL, Shaw LK, Pagnanelli R, et al. Prevalence and predictors of mechanical dyssynchrony as defined by phase analysis in patients with left ventricular dysfunction undergoing gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2011;18:24-30.CrossRefPubMedGoogle Scholar
- 16.Uebleis C, Hellweger S, Laubender RP, Becker A, Shon HY, Lehner S, et al. Left ventricular dyssynchrony assessed by gated SPECT phase analysis in an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy. Eur J Nucl Med Mol Imaging 2012;39:1561-9.CrossRefPubMedGoogle Scholar
- 19.Friehling M, Chen J, Saba S, Bazaz R, Scharrzman D, Adelstein EC, et al. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and predict outcome using a single injection gated SPECT protocol. Circ Cardiovasc Imaging 2011;4:532-9.CrossRefPubMedPubMedCentralGoogle Scholar